Thanos Tzounopoulos PhD, Pittsburgh Hearing Research Center, Pittsburgh University

Dr. Tzounopoulos and Dr. Peter Wipf, also from Pittsburgh University, have developed a new compound for tinnitus which is structurally related to the FDA approved epilepsy drug, Retigabine. The new compound, known as RL-81, is now in the pre-clinical test phase which is a required step before human testing is initiated.

Learn more about Dr. Tzounopoulos and his research.

Donate to Dr. Tzounopoulos’ research.

Select Designation ‘Tinnitus Research’ to direct your donation to Dr. Tzounopoulos.

98% of your donation will go to Dr. Tzounopoulos’ research.